Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Alopecia areata is reversible because hair follicles can regenerate due to stem cells.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Etanercept may not prevent alopecia areata from coming back.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Certain immune cells help hair growth by regulating iron in the skin.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

People with alopecia areata often have abnormal thyroid hormones, thyroid antibodies, antinuclear antibodies, low vitamin D, and high C-reactive protein levels.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Apremilast may help treat hair loss in alopecia areata.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Thymic epithelial cells may be related to skin stem cells.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.